Mechanistic prediction of apixaban and rivaroxaban secretion into human milk and infant systemic exposure through an integrated physiologically based pharmacokinetic framework
Drug Metabolism and Disposition · 2026-05 · 54 (5) · 100271
DOI: 10.1016/j.dmd.2026.100271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-05. Verfasst von Bofang Yi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Binghamton University, State University of New York, Binghamton, New York. Hauptthemen laut MEDLINE: Milk, Human, Rivaroxaban, Pyrazoles, Models, Biological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Office of Women's Health, US Food and Drug Administration.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Binghamton University, State University of New York, Binghamton, New York.
- Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York.
- Department of Pharmacology, Department of Medicine-Cardiology Division, SUNY Upstate Medical University, Syracuse, New York.
- Department of Nonclinical Development and Clinical Pharmacology, Ultragenyx Pharmaceutical Inc, Brisbane, California.
- Department of Pharmaceutical Sciences, Binghamton University, State University of New York, Binghamton, New York. Electronic address: zhangt@binghamton.edu.
Förderung
- Office of Women's Health
- US Food and Drug Administration
Zitieren
APA
Yi, B., Bae, S. H., Yang, Y., Jiang, L., Chen, S., Stratigakis, A., Zhao, Z., Rahman, M. A., Li, Y., Wang, X. S., Zou, P., & Zhang, T. (2026). Mechanistic prediction of apixaban and rivaroxaban secretion into human milk and infant systemic exposure through an integrated physiologically based pharmacokinetic framework. Drug Metabolism and Disposition, 54(5), 100271. https://doi.org/10.1016/j.dmd.2026.100271
Vancouver
Yi B, Bae SH, Yang Y, Jiang L, Chen S, Stratigakis A, et al. Mechanistic prediction of apixaban and rivaroxaban secretion into human milk and infant systemic exposure through an integrated physiologically based pharmacokinetic framework. Drug Metabolism and Disposition. 2026;54(5):100271. doi:10.1016/j.dmd.2026.100271
BibTeX
@article{Yi2026,
author = {Yi, Bofang and Bae, Sung Hun and Yang, Yongzong and Jiang, Linda and Chen, Shirley and Stratigakis, Allesandra and Zhao, Zhongyuan and Rahman, Mohammad Asikur and Li, Yanyan and Wang, Xinrui Sarea and Zou, Peng and Zhang, Tao},
title = {Mechanistic prediction of apixaban and rivaroxaban secretion into human milk and infant systemic exposure through an integrated physiologically based pharmacokinetic framework},
journal = {Drug Metabolism and Disposition},
year = {2026},
volume = {54},
number = {5},
pages = {100271},
doi = {10.1016/j.dmd.2026.100271}
}
EUVIMED